United Capital Management Of Ks, Inc. Gilead Sciences, Inc. Transaction History

United Capital Management Of Ks, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$60.0 - $68.46 $483,660 - $551,856	-8,061 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$56.65 - $64.55 $22,773 - $25,949	402 Added 5.25%	8,061 $470,000
Q3 2020 Oct 19, 2020	BUY	$62.1 - $78.08 $25,398 - $31,934	409 Added 5.64%	7,659 $484,000
Q2 2020 Jul 17, 2020	BUY	$72.34 - $84.0 $524,465 - $609,000	7,250 New	7,250 $558,000

1,905

1.02B

12M

9.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of United Capital Management Of Ks, Inc., based on Form 13F filings with the SEC.

Stay updated on United Capital Management Of Ks, Inc. with notifications on news.